Security key
20454B104
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)
CUSIP: 20454B104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 180,577,721
- Total 13F shares
- 108,253,035
- Share change
- -213,332
- Total reported value
- $281,458,749
- Put/Call ratio
- 13769%
- Price per share
- $2.60
- Number of holders
- 103
- Value change
- +$738,261
- Number of buys
- 43
- Number of sells
- 64
Report period
Q2 2025
Institutions
103
Top holders
10
CMPX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Compass Therapeutics, Inc. SEC filings
Compass Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 20454B104
Recent filing periods:
Top shareholders of CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
22,362,850
|
$42,489,415 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.1%
|
11,052,632
|
$21,000,001 | — | 31 Mar 2025 | |
| Blackstone Inc. |
13F
|
Company |
5.6%
|
10,025,151
|
$19,047,787 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
13D/G
|
Company |
4.1%
from 13D/G
|
8,442,783
|
$16,041,288 | — | 31 Mar 2025 | |
| Enavate Sciences GP, LLC |
13F
|
Company |
4.3%
|
7,788,150
|
$14,797,485 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.9%
|
7,109,090
|
$13,507,272 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13D/G
13F
|
Adage Capital Management, L.P. · Company |
4.4%
|
5,994,810
|
$11,629,931 | $0 | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.7%
|
4,962,955
|
$9,429,615 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
4,838,006
|
$9,192,212 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.3%
|
4,134,287
|
$7,855,146 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2%
|
3,556,023
|
$6,756,444 | — | 31 Mar 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.6%
|
2,954,712
|
$5,613,953 | — | 31 Mar 2025 | |
| Vered Bisker-Leib |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
4,877,551
mixed-class rows
|
$4,530,418 | — | 08 Feb 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
2,364,896
|
$4,494,651 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
2,185,480
|
$4,152,412 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,949,677
|
$3,704,386 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.52%
|
940,784
|
$1,787,000 | — | 31 Mar 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
874,869
|
$1,662,251 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
839,176
|
$1,594,434 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
803,138
|
$1,525,962 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.3%
|
547,498
|
$1,040,246 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.3%
|
545,088
|
$1,035,667 | — | 31 Mar 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.25%
|
448,164
|
$851,512 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
383,503
|
$728,656 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.19%
|
340,772
|
$647,467 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
321,500
|
$610,850 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
304,504
|
$578,558 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
297,880
|
$565,972 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
243,565
|
$462,774 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
233,522
|
$443,692 | — | 31 Mar 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.13%
|
228,317
|
$433,802 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.12%
|
222,505
|
$422,760 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
178,002
|
$338,204 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
170,607
|
$324,153 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
152,851
|
$290,417 | — | 31 Mar 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.08%
|
150,000
|
$285,000 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
138,802
|
$264,023 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
131,497
|
$249,844 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
131,237
|
$249,350 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.07%
|
130,807
|
$248,533 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
120,029
|
$228,049 | — | 31 Mar 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.07%
|
120,000
|
$228,000 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
118,731
|
$225,589 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
102,041
|
$193,878 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
78,294
|
$148,759 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.04%
|
73,682
|
$139,996 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.03%
|
62,844
|
$119,404 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
61,213
|
$116,305 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
61,040
|
$115,976 | — | 31 Mar 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.03%
|
58,700
|
$111,530 | — | 31 Mar 2025 |
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q2 2025
As of 30 Jun 2025,
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,253,035 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, Blackstone Inc., ENAVATE SCIENCES GP, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Vivo Capital, LLC, MPM BIOIMPACT LLC, Rock Springs Capital Management LP, and VANGUARD GROUP INC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
107
Q2 2025 holders
103
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.